Thin cutaneous melanoma: immunohistochemical expression of endoglin, VEGF-C and nestin
暂无分享，去创建一个
[1] M. Suppa,et al. Melanoma Epidemiology and Sun Exposure , 2020, Acta dermato-venereologica.
[2] L. Prosen,et al. Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects , 2015, Cancers.
[3] C. Sorenson,et al. PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis. , 2015, Clinical science.
[4] Josep Malvehy,et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. , 2012, European journal of cancer.
[5] R. Bonamigo,et al. MMP-2 and TIMP-2 in cutaneous melanoma: association with prognostic factors and description in cutaneous metastases. , 2011, The American Journal of dermatopathology.
[6] Claus Garbe,et al. The natural course of cutaneous melanoma , 2004, Journal of surgical oncology.
[7] A. Cattelan,et al. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma. , 1996, British Journal of Cancer.